Treating comorbid substance use disorders in schizophrenia (Q37760932)

22 August 2017

1 reference

title

Treating comorbid substance use disorders in schizophrenia (English)

1 reference

22 August 2017

0 references

0 references

Joel A King

2

0 references

Dan I. Lubman

object named as

Dan I Lubman

series ordinal

1

0 references

author name string

David J Castle

series ordinal

3

1 reference

22 August 2017

1 January 2010

1 reference

International Review of Psychiatry

22 August 2017

1 reference

22 August 2017

22

1 reference

22 August 2017

2

1 reference

22 August 2017

191-201

1 reference

Comparison of olanzapine to risperidone in substance-abusing individuals with schizophrenia.

22 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

Evaluation of a motivational interview for substance use within psychiatric in-patient services

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

Aripiprazole in schizophrenia with cocaine dependence: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

A comparison of long-term and short-term residential treatment programs for dual diagnosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

A neurobiological basis for substance abuse comorbidity in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

Assertive community treatment for patients with co-occurring severe mental illness and substance use disorder: a clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

Review of integrated mental health and substance abuse treatment for patients with dual disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

A Review of Treatments for People with Severe Mental Illnesses and Co-Occurring Substance Use Disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

Comparison of ACT and standard case management for delivering integrated treatment for co-occurring disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

Schizophrenia and co-occurring substance use disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

Substance abuse and schizophrenia: pharmacotherapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

Reasons for cannabis use in men with and without psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

Cognitive-behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18-month outcomes of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

The reliability and validity of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

Psychotic symptom and cannabis relapse in recent-onset psychosis. Prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

Models of co-occurring substance misuse and psychosis: are personality traits the missing link?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

A group intervention which assists patients with dual diagnosis reduce their drug use: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

The self-medication hypothesis of substance use disorders: a reconsideration and recent applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

Olanzapine treatment for patients with schizophrenia and substance abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

Addiction, a condition of compulsive behaviour? Neuroimaging and neuropsychological evidence of inhibitory dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

Dual diagnosis: a review of etiological theories

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

Tobacco smoking within psychiatric inpatient settings: biopsychosocial perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

Medication noncompliance and substance abuse among patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

Increased extrapyramidal symptoms in patients with schizophrenia and a comorbid substance use disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

Antipsychotic drug treatment of schizophrenic patients with substance abuse disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

Cocaine abuse in schizophrenic patients treated with olanzapine versus haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

The efficacy of olanzapine for decreasing cue-elicited craving in individuals with schizophrenia and cocaine dependence: a preliminary report.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

Flupenthixol in relapse prevention in schizophrenics with comorbid alcoholism: results from an open clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

Motivations That Maintain Substance Use Among Individuals With Psychotic Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

Substance misuse in first-episode psychosis: 15-month prospective follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

Neurocognitive and neuroimaging evidence of behavioural dysregulation in human drug addiction: implications for diagnosis, treatment and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

Effects of cannabis use on outcomes of psychotic disorders: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

Housing instability and homelessness among rural schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

In search of how people change. Applications to addictive behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

Substance misuse in first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261003689958

10.3109/09540261003689958

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20504059